세계의 전자처방(E-Prescribing) 시스템 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

The global market for E-Prescribing System was estimated to be worth US$ 3618 million in 2024 and is forecast to a readjusted size of US$ 11686 million by 2031 with a CAGR of 18.3% during the forecast period 2025-2031.

E-prescribing or electronic prescribing is a process involving the electronic generation and sending of prescription orders for the convenience of medical practitioners or physicians, allowing them to transmit prescriptions directly from the point of care to a pharmacy. E-prescribing enhances the safety of patients and the quality of care, since there is no manual writing involved and thus there is less probability of prescription errors. In addition, e-prescribing also helps conduct security checks, encapsulate medical lists, and compile the complete historical data of a patient.

With the continuous advancement of medical informatization, electronic prescription systems (e-prescribing systems) are rapidly gaining popularity worldwide, becoming a crucial tool for hospitals, pharmacies, and clinics to improve efficiency, reduce errors, and optimize patient management.

Key factors driving market growth include: First, policy support and regulatory support. Many European and American countries have incorporated e-prescribing into their healthcare oversight systems and have passed legislation to promote the deep integration of electronic health records (EHRs) and prescription systems, providing a solid foundation for the industry's development. Second, the demand for medical error prevention is increasing. E-prescribing systems, through drug databases, allergy warnings, and interaction detection, effectively reduce the risks associated with unclear handwriting or incorrect medication prescriptions. Third, the rise of telemedicine and mobile health has fueled demand for efficient, cloud-based, mobile-enabled prescription management systems, broadening their application scenarios.

However, market development still faces certain challenges. Tightening data privacy regulations, technical barriers to cross-platform system compatibility, and cost concerns among small and medium-sized medical institutions are currently the main obstacles to market adoption. Furthermore, developing countries still lack sufficient network infrastructure and medical staff training, which may limit market penetration in the short term. In terms of the current market landscape, North America holds a dominant position, boasting a relatively mature technology platform and healthcare system. Europe follows closely behind, with several countries promoting national e-prescription platforms. The Asia-Pacific region is the fastest-growing region, with policy guidance and the development of primary healthcare information technology in countries such as China, India, and Japan injecting new vitality into the market. Key market participants include Surescripts, Oracle, Veradigm, and Athenahealth, while also attracting numerous cloud service providers and medical AI startups.

In the future, e-prescription systems will evolve towards AI-assisted prescribing, personalized drug recommendations, and deep integration with automated medical insurance settlement systems. System intelligence, platform-based architecture, and interoperability will be key competitive drivers. As the global demand for efficient allocation of medical resources continues to rise, the e-prescription market will continue to unleash enormous potential in the digital health wave, becoming an indispensable component of smart healthcare.

This report aims to provide a comprehensive presentation of the global market for E-Prescribing System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of E-Prescribing System by region & country, by Type, and by Application.

The E-Prescribing System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding E-Prescribing System.

Market Segmentation

By Company

• Surescripts
• Henry Schein
• Oracle
• HealthFusion
• Veradigm
• Athenahealth
• Bizmatics
• EClinicalWorks
• EM Systems
• iCoreConnect
• DrFirst
• NXGN Management
• MediRecords

Segment by Type

• Stand-Alone Systems
• Integrated Systems

Segment by Application

• Hospitals
• Office-Based Physicians

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of E-Prescribing System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of E-Prescribing System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of E-Prescribing System in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 E-Prescribing System Product Introduction
• 1.2 Global E-Prescribing System Market Size Forecast (2020-2031)
• 1.3 E-Prescribing System Market Trends & Drivers
  • 1.3.1 E-Prescribing System Industry Trends
  • 1.3.2 E-Prescribing System Market Drivers & Opportunity
  • 1.3.3 E-Prescribing System Market Challenges
  • 1.3.4 E-Prescribing System Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global E-Prescribing System Players Revenue Ranking (2024)
• 2.2 Global E-Prescribing System Revenue by Company (2020-2025)
• 2.3 Key Companies E-Prescribing System Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies E-Prescribing System Product Offered
• 2.5 Key Companies Time to Begin Mass Production of E-Prescribing System
• 2.6 E-Prescribing System Market Competitive Analysis
  • 2.6.1 E-Prescribing System Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by E-Prescribing System Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in E-Prescribing System as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Stand-Alone Systems
  • 3.1.2 Integrated Systems
• 3.2 Global E-Prescribing System Sales Value by Type
  • 3.2.1 Global E-Prescribing System Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global E-Prescribing System Sales Value, by Type (2020-2031)
  • 3.2.3 Global E-Prescribing System Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospitals
  • 4.1.2 Office-Based Physicians
• 4.2 Global E-Prescribing System Sales Value by Application
  • 4.2.1 Global E-Prescribing System Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global E-Prescribing System Sales Value, by Application (2020-2031)
  • 4.2.3 Global E-Prescribing System Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global E-Prescribing System Sales Value by Region
  • 5.1.1 Global E-Prescribing System Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global E-Prescribing System Sales Value by Region (2020-2025)
  • 5.1.3 Global E-Prescribing System Sales Value by Region (2026-2031)
  • 5.1.4 Global E-Prescribing System Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America E-Prescribing System Sales Value, 2020-2031
  • 5.2.2 North America E-Prescribing System Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe E-Prescribing System Sales Value, 2020-2031
  • 5.3.2 Europe E-Prescribing System Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific E-Prescribing System Sales Value, 2020-2031
  • 5.4.2 Asia Pacific E-Prescribing System Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America E-Prescribing System Sales Value, 2020-2031
  • 5.5.2 South America E-Prescribing System Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa E-Prescribing System Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa E-Prescribing System Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions E-Prescribing System Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions E-Prescribing System Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States E-Prescribing System Sales Value, 2020-2031
  • 6.3.2 United States E-Prescribing System Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States E-Prescribing System Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe E-Prescribing System Sales Value, 2020-2031
  • 6.4.2 Europe E-Prescribing System Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe E-Prescribing System Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China E-Prescribing System Sales Value, 2020-2031
  • 6.5.2 China E-Prescribing System Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China E-Prescribing System Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan E-Prescribing System Sales Value, 2020-2031
  • 6.6.2 Japan E-Prescribing System Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan E-Prescribing System Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea E-Prescribing System Sales Value, 2020-2031
  • 6.7.2 South Korea E-Prescribing System Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea E-Prescribing System Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia E-Prescribing System Sales Value, 2020-2031
  • 6.8.2 Southeast Asia E-Prescribing System Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia E-Prescribing System Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India E-Prescribing System Sales Value, 2020-2031
  • 6.9.2 India E-Prescribing System Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India E-Prescribing System Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Surescripts
  • 7.1.1 Surescripts Profile
  • 7.1.2 Surescripts Main Business
  • 7.1.3 Surescripts E-Prescribing System Products, Services and Solutions
  • 7.1.4 Surescripts E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.1.5 Surescripts Recent Developments
• 7.2 Henry Schein
  • 7.2.1 Henry Schein Profile
  • 7.2.2 Henry Schein Main Business
  • 7.2.3 Henry Schein E-Prescribing System Products, Services and Solutions
  • 7.2.4 Henry Schein E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Henry Schein Recent Developments
• 7.3 Oracle
  • 7.3.1 Oracle Profile
  • 7.3.2 Oracle Main Business
  • 7.3.3 Oracle E-Prescribing System Products, Services and Solutions
  • 7.3.4 Oracle E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.3.5 Oracle Recent Developments
• 7.4 HealthFusion
  • 7.4.1 HealthFusion Profile
  • 7.4.2 HealthFusion Main Business
  • 7.4.3 HealthFusion E-Prescribing System Products, Services and Solutions
  • 7.4.4 HealthFusion E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.4.5 HealthFusion Recent Developments
• 7.5 Veradigm
  • 7.5.1 Veradigm Profile
  • 7.5.2 Veradigm Main Business
  • 7.5.3 Veradigm E-Prescribing System Products, Services and Solutions
  • 7.5.4 Veradigm E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.5.5 Veradigm Recent Developments
• 7.6 Athenahealth
  • 7.6.1 Athenahealth Profile
  • 7.6.2 Athenahealth Main Business
  • 7.6.3 Athenahealth E-Prescribing System Products, Services and Solutions
  • 7.6.4 Athenahealth E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.6.5 Athenahealth Recent Developments
• 7.7 Bizmatics
  • 7.7.1 Bizmatics Profile
  • 7.7.2 Bizmatics Main Business
  • 7.7.3 Bizmatics E-Prescribing System Products, Services and Solutions
  • 7.7.4 Bizmatics E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Bizmatics Recent Developments
• 7.8 EClinicalWorks
  • 7.8.1 EClinicalWorks Profile
  • 7.8.2 EClinicalWorks Main Business
  • 7.8.3 EClinicalWorks E-Prescribing System Products, Services and Solutions
  • 7.8.4 EClinicalWorks E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.8.5 EClinicalWorks Recent Developments
• 7.9 EM Systems
  • 7.9.1 EM Systems Profile
  • 7.9.2 EM Systems Main Business
  • 7.9.3 EM Systems E-Prescribing System Products, Services and Solutions
  • 7.9.4 EM Systems E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.9.5 EM Systems Recent Developments
• 7.10 iCoreConnect
  • 7.10.1 iCoreConnect Profile
  • 7.10.2 iCoreConnect Main Business
  • 7.10.3 iCoreConnect E-Prescribing System Products, Services and Solutions
  • 7.10.4 iCoreConnect E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.10.5 iCoreConnect Recent Developments
• 7.11 DrFirst
  • 7.11.1 DrFirst Profile
  • 7.11.2 DrFirst Main Business
  • 7.11.3 DrFirst E-Prescribing System Products, Services and Solutions
  • 7.11.4 DrFirst E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.11.5 DrFirst Recent Developments
• 7.12 NXGN Management
  • 7.12.1 NXGN Management Profile
  • 7.12.2 NXGN Management Main Business
  • 7.12.3 NXGN Management E-Prescribing System Products, Services and Solutions
  • 7.12.4 NXGN Management E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.12.5 NXGN Management Recent Developments
• 7.13 MediRecords
  • 7.13.1 MediRecords Profile
  • 7.13.2 MediRecords Main Business
  • 7.13.3 MediRecords E-Prescribing System Products, Services and Solutions
  • 7.13.4 MediRecords E-Prescribing System Revenue (US$ Million) & (2020-2025)
  • 7.13.5 MediRecords Recent Developments

8 Industry Chain Analysis

• 8.1 E-Prescribing System Industrial Chain
• 8.2 E-Prescribing System Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 E-Prescribing System Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 E-Prescribing System Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer